Back to Search
JOSHUA MENENDEZ, M.D.
M.D.
Neurological Surgery Physician
NPI: 1780905380IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
31449(AL)
CMS Specialties
PrimaryNEUROSURGERY
Education
UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
PMID 19082476·Int J Oncol·2009
8-other
Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer.
PMID 19181734·Clin Chem·2009
6-review
Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
PMID 18813848·Int J Mol Med·2008
8-other
tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO).
PMID 19094209·BMC Cancer·2008
8-other
Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?
PMID 17983482·Breast Cancer Res·2007
8-other
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.
PMID 17882277·Nat Rev Cancer·2007
6-review
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells.
PMID 17490486·BMC Cancer·2007
4-observational
Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.
PMID 16778562·Curr Opin Clin Nutr Metab Care·2006
6-review
Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9).
PMID 17168666·Curr Pharm Biotechnol·2006
6-review
DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
PMID 17089011·Int J Mol Med·2006
8-other
Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.
PMID 16847284·J Clin Oncol·2006
8-other
A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
PMID 16406575·Eur J Cancer·2006
8-other
Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
PMID 15870086·Ann Oncol·2005
8-other
Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.
PMID 16264182·J Natl Cancer Inst·2005
8-other
Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
PMID 15901996·Eur J Cancer Prev·2005
8-other
The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
PMID 15870863·Int J Oncol·2005
8-other
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
PMID 15657900·Int J Cancer·2005
8-other
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification.
PMID 15642702·Ann Oncol·2005
8-other
Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
PMID 15607569·Med Hypotheses·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 SAINT VINCENTS DR STE 700
BIRMINGHAM, AL 35205 - Phone
- (205) 933-8981
Quick Facts
- NPI
- 1780905380
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile